Abiopharma

Clinical trial NCT07469176: start date: 2026-08-15 → 2026-09-15.

Clinical trial NCT07081997: start date: 2026-04-16 → 2026-05-07.

Clinical trial NCT06190613 updates: 1. completion date: 2026-08-31 → 2026-12-31 2. primary completion date: 2026-08-31 → 2026-12-31 3. enrollment: 100 → 110 participants

Clinical trial NCT07659964 updates: 1. completion date: 2027-06-01 → 2026-12-01 2. primary completion date: 2027-06-01 → 2026-12-01 3. primary purpose: BASIC_SCIENCE → OTHER

Clinical trial NCT07629583 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-10-31

Clinical trial NCT06052631: start date: 2026-08-11 → 2026-08-12.

Clinical trial NCT07532785 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-08-01 3. primary completion date: 2026-11-01 → 2027-03-01

Clinical trial NCT06124625 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-09-01 → 2025-09-08 3. primary completion date: 2025-09-01 → 2025-09-08 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07037420 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2027-11-11 → 2026-06-24 3. primary completion date: 2027-01-08 → 2026-06-24 4. enrollment: 60 → 8 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07022717 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 24 → 22 participants 3. enrollment type: ESTIMATED → ACTUAL